BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4591788)

  • 1. MSH-release inhibiting factors: recent studies.
    Kastin AJ; Plotnikoff NP; Viosca S; Anderson MS; Schally AV
    Yale J Biol Med; 1973 Dec; 46(5):617-22. PubMed ID: 4591788
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of melanophore stimulating hormone (MSH) release.
    Hadley ME; Bower A; Hruby VJ
    Yale J Biol Med; 1973 Dec; 46(5):602-16. PubMed ID: 4544339
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurohypophyseal hormones as precursors of hypophysiotropic hormones.
    Schwartz IL; Walter R
    Isr J Med Sci; 1974 Oct; 10(10):1288-93. PubMed ID: 4373416
    [No Abstract]   [Full Text] [Related]  

  • 4. Melanophore stimulating hormone: release inhibition by ring structures of neurohypophysial hormones.
    Hruby VJ; Smith CW; Bower A; Hadley ME
    Science; 1972 Jun; 176(4041):1331-2. PubMed ID: 4624585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that Pro-Leu-Gly-NH 2 , tocinoic acid, and des-Cys-tocinoic acid do not affect secretion of melanocyte stimulating hormone.
    Grant NH; Clark DE; Rosanoff EI
    Biochem Biophys Res Commun; 1973 Mar; 51(1):100-6. PubMed ID: 4540644
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and structure of hypothalamic MSH release-inhibition hormone.
    Nair RM; Kastin AJ; Schally AV
    Biochem Biophys Res Commun; 1971 Jun; 43(6):1376-81. PubMed ID: 4398196
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiological correlates of melanocyte-stimulating hormone activity in the frog.
    Denman PM; Miller LH; Sandman CA; Schally AV; Kastin AJ
    J Comp Physiol Psychol; 1972 Jul; 80(1):59-65. PubMed ID: 4557920
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-activity studies of MSH-release-inhibiting hormone.
    Celis ME; Hase S; Walter R
    FEBS Lett; 1972 Nov; 27(2):327-30. PubMed ID: 4352026
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of MSH-release-inhibiting hormone by a particulate preparation of hypothalami: mechanisms of oxytocin inactivation.
    Walter R; Griffiths EC; Hooper KC
    Brain Res; 1973 Oct; 60(2):449-57. PubMed ID: 4587290
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for the release of MSH by phenothiazine ataraxics.
    Scott GT; Stillings WA
    Endocrinology; 1972 Feb; 90(2):545-51. PubMed ID: 4333138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypothalamic releasing hormones. I. Structure, sources of formation, physiologic effects].
    Dedov II; Dedov VI
    Usp Sovrem Biol; 1980; 89(1):141-58. PubMed ID: 6104883
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.
    Kastin AJ; Schally AV; Viosca S
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1437-9. PubMed ID: 5316453
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbon-13 NMR studies of peptide hormones and their components.
    Smith IC; Deslauriers R; Saitô H; Walter R; Garrigou-Lagrange C; McGregor H; Sarantakis D
    Ann N Y Acad Sci; 1973 Dec; 222():597-627. PubMed ID: 4361873
    [No Abstract]   [Full Text] [Related]  

  • 14. Site of inactivation of melanocyte-stimulating hormone-release-inhibiting hormone by human plasma.
    Nair RM; Redding TW; Kastin AJ; Schally AV
    Biochem Pharmacol; 1973 Aug; 22(15):1915-9. PubMed ID: 4578947
    [No Abstract]   [Full Text] [Related]  

  • 15. Bioassay of pigmentary hormones.
    Abe K; Nicholson EW
    Methods Enzymol; 1975; 37():121-30. PubMed ID: 165368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nle4, D-Phe7]-alpha-MSH: a superpotent melanotropin with prolonged action on vertebrate chromatophores.
    Hadley ME; Mieyr JH; Martin BE; Castrucci AM; Hruby VJ; Sawyer TK; Powers EA; Rao KR
    Comp Biochem Physiol A Comp Physiol; 1985; 81(1):1-6. PubMed ID: 2859941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive method for the bioassay of melanocyte stimulating hormone in human saliva.
    Innes DL; Ritman L; Tansy MF
    J Dent Res; 1974; 53(4):814-20. PubMed ID: 4546332
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
    Huidobro-Toro JP; De Carolis AS; Longo VG
    Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative MSH release-inhibiting activities of tocinoic acid (the ring of oxytocin), and L-pro-L-leu-gly-NH 2 (the side chain of oxytocin).
    Bower A; Hadley ME; Hruby VJ
    Biochem Biophys Res Commun; 1971 Dec; 45(5):1185-91. PubMed ID: 5135504
    [No Abstract]   [Full Text] [Related]  

  • 20. Melanotropin bioassays: in vitro and in vivo comparisons.
    Castrucci AM; Hadley ME; Hruby VJ
    Gen Comp Endocrinol; 1984 Jul; 55(1):104-11. PubMed ID: 6611282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.